| 1 |
15735921 | A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma. | 2005 Feb |
1 |
| 2 |
14726661 | A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer. | 2004 Jan |
1 |
| 3 |
12151959 | Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies. | 2002 Aug |
1 |
| 4 |
11336465 | A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study. | 2001 May 4 |
1 |
| 5 |
11398891 | Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors. | 2001 Apr |
1 |
| 6 |
10071262 | Phase I and pharmacologic study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer. | 1999 Mar |
1 |
| 7 |
10355583 | Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding study. | 1999 Mar |
1 |
| 8 |
9553662 | High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic study. | 1998 Feb |
7 |
| 9 |
8996136 | Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer. | 1997 Jan |
3 |
| 10 |
8996140 | Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study. | 1997 Jan |
1 |
| 11 |
8648378 | Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors. | 1996 Apr |
8 |
| 12 |
8888741 | Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. | 1996 Nov |
2 |
| 13 |
9816325 | Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor. | 1996 Sep |
1 |